Exact Mass: 283.200815

Exact Mass Matches: 283.200815

Found 44 metabolites which its exact mass value is equals to given mass value 283.200815, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Levallorphan

(1R,9R,10R)-17-(prop-2-en-1-yl)-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2(7),3,5-trien-4-ol

C19H25NO (283.193604)


An opioid antagonist with properties similar to those of naloxone; in addition it also possesses some agonist properties. It should be used cautiously; levallorphan reverses severe opioid-induced respiratory depression but may exacerbate respiratory depression such as that induced by alcohol or other non-opioid central depressants. (From Martindale, The Extra Pharmacopoeia, 30th ed, p683) D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D009292 - Narcotic Antagonists C78272 - Agent Affecting Nervous System > C681 - Opiate Antagonist

   

Histrionicotoxin

(2S,6R,10S,11S)-11-[(E)-but-1-en-3-ynyl]-2-[(E)-pent-2-en-4-ynyl]-1-azaspiro[5.5]undecan-10-ol

C19H25NO (283.193604)


An azaspiro compound that is 1-azaspiro[5.5]undecane substituted by a hydroxy group at position 8, a but-1-en-3-yn-1-yl group at position 7 and a pent-3-en-1-yn-5-yl group at position 2 (the 2S,6R,7S,8S stereoisomer).

   

N-Dealkylated tolterodine

4-methyl-2-[(1R)-1-phenyl-3-[(propan-2-yl)amino]propyl]phenol

C19H25NO (283.193604)


N-Dealkylated tolterodine is only found in individuals that have used or taken tolterodine. N-Dealkylated tolterodine is a metabolite of tolterodine. N-Dealkylated tolterodine belongs to the family of Diphenylmethanes. These are compounds containing a diphenylmethane moiety, which consists of a methane wherein two hydrogen atoms are replaced by two phenyl groups.

   

(2S)-(+)-5-(1,3,5-Trimethylpyrazol-4-YL)-2-(dimethylamino)tetralin

N,N-dimethyl-5-(1,3,5-trimethyl-1H-pyrazol-4-yl)-1,2,3,4-tetrahydronaphthalen-2-amine

C18H25N3 (283.204837)


   

Tesmilifene

N,N-Diethyl-2-((4-phenylmethyl)phenoxy)-ethanamine hydrochloride

C19H25NO (283.193604)


C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist

   

N-(ortho-methoxybenzyl)-4-ethylamphetamine

N-(ortho-methoxybenzyl)-4-ethylamphetamine

C19H25NO (283.193604)


   

(2E,4E,12Z)-3-Methylbutylamide-2,4,12-Tetradecatriene-8,10-diynoic aci

(2E,4E,12Z)-3-Methylbutylamide-2,4,12-Tetradecatriene-8,10-diynoic aci

C19H25NO (283.193604)


   

tetradeca-2E,4E,6E,10E-tetraen-8-ynoic acid piperidide

tetradeca-2E,4E,6E,10E-tetraen-8-ynoic acid piperidide

C19H25NO (283.193604)


   

2,4-Tetradecadien-8,10-diynoic acid piperidide

2,4-Tetradecadien-8,10-diynoic acid piperidide

C19H25NO (283.193604)


   

1-methyl-2-[(Z)-4-nonenyl]-4(1H)-quinolone

1-methyl-2-[(Z)-4-nonenyl]-4(1H)-quinolone

C19H25NO (283.193604)


   
   

Propoxyphene carbinol

[S-(R*,S*)]-alpha-[2-(dimethylamino)-1-methylethyl]-alpha-phenylphenethyl alcohol

C19H25NO (283.193604)


   

(2S,6R,7S,8S)-7-((E)-but-1-en-3-yn-1-yl)-2-((E)-pent-2-en-4-yn-1-yl)-1-azaspiro[5.5]undecan-8-ol

(2S,6R,7S,8S)-7-((E)-but-1-en-3-yn-1-yl)-2-((E)-pent-2-en-4-yn-1-yl)-1-azaspiro[5.5]undecan-8-ol

C19H25NO (283.193604)


   

N-Dealkylatedtolterodine

4-methyl-2-[(1S)-1-phenyl-3-[(propan-2-yl)amino]propyl]phenol

C19H25NO (283.193604)


   

Drobuline

Drobuline

C19H25NO (283.193604)


C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent

   

1,2-Ethanediamine,N1-(phenylmethyl)-N2-[2-[(phenylmethyl)amino]ethyl]-

1,2-Ethanediamine,N1-(phenylmethyl)-N2-[2-[(phenylmethyl)amino]ethyl]-

C18H25N3 (283.204837)


   

2-amino-1,1-diphenylheptan-1-ol

2-amino-1,1-diphenylheptan-1-ol

C19H25NO (283.193604)


   

1-Benzyl-[1,4-bipiperidine]-4-carbonitrile

1-Benzyl-[1,4-bipiperidine]-4-carbonitrile

C18H25N3 (283.204837)


   

Alentemol

Alentemol

C19H25NO (283.193604)


C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist

   

Quaternary ammonium compounds, benzyl-C12-14-alkyldimethyl, chlorides

Quaternary ammonium compounds, benzyl-C12-14-alkyldimethyl, chlorides

C17H30ClN (283.20666500000004)


   
   
   

1-Butanol,2-[bis(phenylmethyl)amino]-3-methyl-, (2S)-

1-Butanol,2-[bis(phenylmethyl)amino]-3-methyl-, (2S)-

C19H25NO (283.193604)


   

(E)-tert-butyl (3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)allyl)carbamate

(E)-tert-butyl (3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)allyl)carbamate

C14H26BNO4 (283.1954786)


   

(2r 3s)-(-)-4-dimethylamino-1 2-dipheny&

(2r 3s)-(-)-4-dimethylamino-1 2-dipheny&

C19H25NO (283.193604)


   

benzyldimethyloctylammonium chloride

benzyldimethyloctylammonium chloride

C17H30ClN (283.20666500000004)


   

levallorphan hydrogen tartrate

levallorphan hydrogen tartrate

C19H25NO (283.193604)


   

Sdccgsbi-0050749.P002

Sdccgsbi-0050749.P002

C19H25NO (283.193604)


   

4-[3-[Methyl(2-phenylethyl)amino]butyl]phenol

4-[3-[Methyl(2-phenylethyl)amino]butyl]phenol

C19H25NO (283.193604)


   
   

[(2R,3S,6S)-3-amino-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-oxanyl]methanol

[(2R,3S,6S)-3-amino-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-oxanyl]methanol

C13H25N5O2 (283.200815)


   

[(2S,3S,6S)-3-amino-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-oxanyl]methanol

[(2S,3S,6S)-3-amino-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-oxanyl]methanol

C13H25N5O2 (283.200815)


   

[(2R,3R,6R)-3-amino-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-oxanyl]methanol

[(2R,3R,6R)-3-amino-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-oxanyl]methanol

C13H25N5O2 (283.200815)


   

[(2S,3S,6R)-3-amino-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-oxanyl]methanol

[(2S,3S,6R)-3-amino-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-oxanyl]methanol

C13H25N5O2 (283.200815)


   

[(2R,3R,6S)-3-amino-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-oxanyl]methanol

[(2R,3R,6S)-3-amino-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-oxanyl]methanol

C13H25N5O2 (283.200815)


   

(E)-Delta-oxomycolate

(E)-Delta-oxomycolate

C16H27O4- (283.1909242)


   

4-Spiro-(N-methylpiperidyl)-2,2-dimethyl-1,2,3,4-tetrahydro-gamma-carboline

4-Spiro-(N-methylpiperidyl)-2,2-dimethyl-1,2,3,4-tetrahydro-gamma-carboline

C18H25N3 (283.204837)


   

3-(1-Methyl-3-piperiden-4-yl)-2-(2-methyl-2-aminopropyl)indole

3-(1-Methyl-3-piperiden-4-yl)-2-(2-methyl-2-aminopropyl)indole

C18H25N3 (283.204837)


   

3-(3-Methyl-3-piperiden-4-yl)-2-(2-methyl-2-aminopropyl)indole

3-(3-Methyl-3-piperiden-4-yl)-2-(2-methyl-2-aminopropyl)indole

C18H25N3 (283.204837)


   

levallorphan

levallorphan

C19H25NO (283.193604)


D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D009292 - Narcotic Antagonists C78272 - Agent Affecting Nervous System > C681 - Opiate Antagonist

   

Tesmilifene

Tesmilifene

C19H25NO (283.193604)


C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist

   

4-methyl-2-[(1R)-1-phenyl-3-(propan-2-ylamino)propyl]phenol

4-methyl-2-[(1R)-1-phenyl-3-(propan-2-ylamino)propyl]phenol

C19H25NO (283.193604)


   

Benzeneethanol, alpha-[2-(dimethylamino)-1-methylethyl]-alpha-phenyl-

Benzeneethanol, alpha-[2-(dimethylamino)-1-methylethyl]-alpha-phenyl-

C19H25NO (283.193604)


   

AS19

AS19

C18H25N3 (283.204837)


AS19 is a potent, selective 5-HT7 receptor agonist with an IC50 value of 0.83 nM and a Ki of 0.6 nM. AS19 is selective for 5-HT7 over 5-HT1A, 5-HT1B, 5-HT1D, and 5-HT5A receptors (Kis = 89.7 nM, 490 nM, 6.6 nM and 98.5 nM, respectively). AS19 enhances memory consolidation and reverses Scopolamine- or Dizocilpine-induced amnesia[1][2][3].